Under rug swept Last Dose, I told you about how money-hungry minions of the federal government are engaging in a campaign of fear and manipulation to protect the interests of their drug-industry cronies. As if that weren't bad enough, consider this: The FDA is also protecting the drug biz from having to report the results of thousands of their medical studies! Here's the scoop: A 2002 FDA law stipulates that any clinical study of a treatment's effectiveness against serious disease - whether it's industry-sponsored, government-backed or independent in nature - must be listed as part of a publicly accessible database, ClinicalTrials.gov. And indeed, more than 90% of the studies conducted by entities like the National Cancer Institute and others are currently listed. Not a bad rate of compliance, right? Hold up a minute, though: According to a recent Associated Press article, the FDA's own reporting (which is no doubt hopelessly slanted in favor of the drug biz, mind you) shows that the pharmaceuticals industry's rate of compliance with this law is LESS THAN 50%. And what's even scarier than this little factoid is that the vast majority of drug-related disease studies are conducted by Big Pharma, yet only 13% of the research posted on ClinicalTrials.gov is from industry-funded studies! Think there's a little bit of research being swept under the rug here? How can this be, you're asking? Isn't this an automatic felony? Technically, yes, the drug-biz fat cats are felons for not coughing up the results of all their clinical drug trials - so the government COULD prosecute them for their blatant deception. There's only one small problem: The way the FDA drafted the law, there's NO PENALTY FOR BREAKING IT! Yep, that's right. When it wrote the law, the FDA made certain of its un-enforceability, thereby accomplishing two things: First, they made sure that drug companies won't have to tell anyone what they know about what their poisons are doing to us; and second, they gave themselves "plausible deniability." It's brilliant - the FDA can point to all these guidelines and laws that seem to show they've got our best interests in mind, but the truth is that they're really designed to give their cronies a free pass! Diabolical, but brilliant. And it really makes you wonder what they're all trying so desperately to hide, doesn't it? More to come in the next Daily Dose... The PSA: Perennially Senseless Assay It's been a while since I've touched on this, but I'd revisit it every month if it meant keeping even one more man from having his prostate fried needlessly (yep, that's exactly what they do, too): As I've said, the PSA (Prostate Specific Antigen) test is useless at best, horrifically misleading at worst... And now, there's even more evidence supporting this assertion you've heard me make so often before. According to a Yahoo Health article (no doubt reprinted with permission from the AP, Reuters, or some other outlet), a "disturbing" new study finds that fully 15% of older men whose PSA readings were considered perfectly normal had prostate cancer - some even with relatively advanced tumors! Of course, I've been saying for years that the PSA test is sloppy - it often finds cancer where there isn't any, and fails to detect it when it's aggressive! So what are the "experts" thinking of doing in response to this? Lowering the PSA's "normal" threshold. Great - now even more men will be undergoing the sometimes manhood-robbing surgery that often leaves them in diapers, many times needlessly. If only these moron MDs would follow up a "positive" PSA test with the one I've been crowing about for years, all this would be a moot point. It's called the AMAS (Anti-Malignan Antibody Screening), and it's safe, cheap, and more than 95% accurate at detecting cancer of any type. You can read up on it in more detail at www.amascancertest.com. If you've got an elevated PSA and your doctor doesn't know about this test, find one who does. Either that or stock up on Depends undergarments. The straight scoop you can always depend on, William Campbell Douglass II, MD | 
